Shopping Cart

Remove All
Your shopping cart is currently empty

NXT629

Name: NXT629
Brand: TargetMol
SKU: T12278
Rating: 4.5 (1 reviews)

😃Good

Catalog No. T12278Cas No. 1454925-59-7

Alias NXT 629

NXT629 is a selective and highly efficient PPAR-α antagonist with anticancer activity. It inhibits PPARδ, PPARγ, Erβ, GR, and TRβ and can be used in research on ovarian cancer and melanoma.

NXT629

😃Good

Purity: 99.07%

Catalog No. T12278Alias NXT 629Cas No. 1454925-59-7

NXT629 is a selective and highly efficient PPAR-α antagonist with anticancer activity. It inhibits PPARδ, PPARγ, Erβ, GR, and TRβ and can be used in research on ovarian cancer and melanoma.

Pack Size	Price	Availability
1 mg	$235	6-8 weeks
2 mg	$347	In Stock
5 mg	$586	6-8 weeks
25 mg	$1,670	6-8 weeks
50 mg	$2,180	6-8 weeks
100 mg	$2,800	6-8 weeks

Bulk & Custom

Add to Cart

Questions

Select Batch

Purity:99.07%

Resource Download

COA

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity

Description	NXT629 is a selective and highly efficient PPAR-α antagonist with anticancer activity. It inhibits PPARδ, PPARγ, Erβ, GR, and TRβ and can be used in research on ovarian cancer and melanoma.
Targets&IC50	PPARα (human):77 nM, PPARγ (human):15 μM, ERβ:15.2 μM, PPARδ (human):6 μM, GR:32.5 μM
In vitro	NXT629 (compound 33) is a potent and selective PPAR-α antagonist with an IC50 of 77 nM for human PPARα, as well as weaker effects on other nuclear hormone receptors (e.g., PPARδ, PPARγ, Erβ, GR, and TRβ) with IC50s of 6.0 μM, 15 μM, 15.2 μM, 32.5 μM, and >100 μM, respectively.[1] The competitive inhibitory ability of NXT629 on PPARα, PPARβ/δ and PPARγ was also validated, with corresponding IC50s of 2.3 μM, 35.1 μM and 6.9 μM, respectively.[2]
In vivo	NXT629 exhibits low oral bioavailability in mice and rats. NXT629 administered intraperitoneally (30 mg/kg once daily for 6 weeks) significantly slowed down the growth of subcutaneous SKOV-3 tumors in nude mice and showed inhibition of subcutaneous B16F10 tumor growth in C57Bl/6 mice. In addition, NXT629 (30 mg/kg, intraperitoneal injection) showed weak anti-angiogenic activity in FGF-induced angiogenesis. NXT629 (3 and 30 mg/kg, intraperitoneal injection) also reduced experimental metastasis of B16F10 melanoma cells in the lungs of mice. [2]
Alias	NXT 629

Chemical Properties

Molecular Weight	609.78
Formula	C₃₅H₃₉N₅O₃S
Cas No.	1454925-59-7
Smiles	O=C1N(N=C(N1CC)CCCC=2C=CC(=CC2)C3=NC=C(C=C3)NS(=O)(=O)C=4C=CC=CC4)CC5=CC=C(C=C5)C(C)(C)C
Relative Density.	1.20 g/cm3 (Predicted)

Storage & Solubility Information

Storage

store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Solubility Information

DMSO: 100 mg/mL (163.99 mM), Sonication is recommended.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	1.6399 mL	8.1997 mL	16.3994 mL	81.9968 mL
5 mM	0.3280 mL	1.6399 mL	3.2799 mL	16.3994 mL
10 mM	0.1640 mL	0.8200 mL	1.6399 mL	8.1997 mL
20 mM	0.0820 mL	0.4100 mL	0.8200 mL	4.0998 mL
50 mM	0.0328 mL	0.1640 mL	0.3280 mL	1.6399 mL
100 mM	0.0164 mL	0.0820 mL	0.1640 mL	0.8200 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:

For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments

A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent

DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。

Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO TargetMol | reagent

(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.

Preparation method for in vivo formula: Take 50 μL DMSO TargetMol | reagent

main solution, add 300 μLPEG300 TargetMol | reagent

mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2O TargetMol | reagent

mix well and clarify

For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc